AKT1 and type 1 diabetes mellitus: According to our results for the MSTN/Akt signaling pathways, the protein expressions of MSTN in muscles were decreased by LIPUS in diabetes rats, indicating that the inhibition of MSTN may contribute to improvements in T1DM-induced skeletal muscle atrophy.